Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- AstraZeneca, Osaka University Aim to Resurrect Ditched Drug Candidates
March 13, 2014
- 19 Pharmacy-Operating Companies Join Bidding Group for Drug Purchasing
March 12, 2014
- Announcement: 7th Annual Marketing Excellence Japan 2014 – Westin Tokyo, May 13 – 14
March 12, 2014
- Eisai to Forge Cross-Regional Biz Units for Oncology, Neurology in July
March 11, 2014
- Otsuka, UCB Japan File Partial Change Application for Monotherapy for E Keppra
March 11, 2014
- Ethical Drug Sales Up 4.7% in January Owing to Growth in Influenza-Related Products: Crecon Report
March 11, 2014
- Takeda Picks Third-Party Investigator for CASE-J Issue, Probe Expected to Take 3 Months
March 11, 2014
- Pfizer Japan Logs 1.2% Sales Increase in FY2013
March 10, 2014
- Eisai, Biogen Idec to Jointly Develop, Commercialize AD Treatments
March 10, 2014
- Asahi Kasei Pharma Exec Hori Picked as Next President
March 10, 2014
- Takeda Submits NDA for Once-Weekly DPP-4 Inhibitor Trelagliptin
March 10, 2014
- US Journal to Revise COI Disclosure in Article Used by Shionogi and Eli Lilly Japan to Promote Cymbalta
March 10, 2014
- 28% of Mainstays to Face New Price Cuts for Long-Listed Drugs: Jiho Survey
March 7, 2014
- Map Software Used to Reorganize MRs’ Marketing Territories Boosts Operating Efficiency at Pfizer Japan
March 7, 2014
- Five Generic Makers See Various Price Reduction Rates under FY2014 NHI Revision
March 6, 2014
- New Price Cuts for Long-Listed Drugs to Pummel MTPC, Astellas: Jiho Tally
March 6, 2014
- Santen Licenses Anti-Endoglin Antibodies from TRACON to Develop Novel Treatments for Retinal Diseases
March 6, 2014
- Samsca Tops January “Mind Share” Ranking in HP Market
March 5, 2014
- Eylea Filed for Diabetic Macular Edema in Japan: Bayer HealthCare
March 5, 2014
- Takeda Extended 3.7 Billion Yen in CASE-J-Linked Grants to Kyoto Univ., 2 Entities; “No COI” Says Pres. Hasegawa
March 4, 2014
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…